Clinicopathological and molecular characteristics associated with pathological complete response in neoadjuvant immunotherapy for breast cancer.

Front Immunol · 2026 · PMC13066237 · PMID 41972153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

Second, some subgroup analyses are based on a limited number of trials, involve heterogeneous definitions and assessment methods, and in some cases demonstrate only marginally significant interaction tests.

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.